Hospira, Inc. v. Janssen Biotech, Inc. et al
| Hospira, Inc. |
| NYU Langone Medical Center, New York University, Janssen Biotech, Inc. and The Kennedy Trust for Rheumatology Research |
| 1:2014cv07049 |
| August 29, 2014 |
| US District Court for the Southern District of New York |
| Foley Square Office |
| XX Out of State |
| Paul A. Crotty |
| Patent |
| 28 U.S.C. ยง 2201 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
60
OPINION AND ORDER: re: 35 MOTION to Sever and Transfer. filed by New York University, Janssen Biotech, Inc., NYU Langone Medical Center, 37 MOTION to Dismiss for Lack of Jurisdiction or Failure to State a Claim on Which Relief May Be Granted. For the foregoing reasons, the motion to dismiss is granted. This order moots the pending motion to sever or transfer. In light of the Court's dismissal of Celltrion's claims against Kennedy, Hospira's claims against Kennedy are dismissed for the reasons stated above and in the Celltrion order. The Clerk of Court is directed to terminate the pending motions and close this case. (Signed by Judge Paul A. Crotty on 12/1/2014) (js) Modified on 12/1/2014 (js).
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
